| 264 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via ATP depletion associated cell death |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 265 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via increased cytosolic calcium |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 266 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased Na-K ATPase activity |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 267 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via glucose depletion |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 268 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via mitochondrial swelling |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 348 |
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory |
Young Jun Kim |
BY-SA |
1799: Inhibition of 11β-HSD
|
360: Decrease, Population growth rate
|
Under Development |
1.93 |
| 349 |
Inhibition of 11β-hydroxylase leading to decresed population trajectory |
Young Jun Kim |
BY-SA |
1796: 11β-hydroxylase inhibition
|
360: Decrease, Population growth rate
|
Under Development |
1.93 |
| 358 |
Chitinase inhibition leading to mortality |
Simon Schmid |
BY-SA |
1806: Inhibition, Chitinase
|
350: Increase, Mortality
|
Under Development |
1.94 |
| 359 |
Chitobiase inhibition leading to mortality |
Simon Schmid |
BY-SA |
1807: Inhibition, Chitobiase
|
350: Increase, Mortality
|
Under Development |
1.94 |
| 360 |
Chitin synthase 1 inhibition leading to mortality |
Simon Schmid |
BY-SA |
1522: Inhibition, Chitin synthase 1
|
350: Increase, Mortality
|
WPHA/WNT Endorsed |
1.94 |
| 361 |
Sulfonylureareceptor binding leading to mortality |
Simon Schmid |
BY-SA |
1525: Increase, Sulfonylurea receptor binding
|
350: Increase, Mortality
|
Under Development |
1.94 |
| 412 |
Endothelial cell dysfunction leading to thromboinflammation |
Luigi Margiotta-Casaluci |
BY-SA |
None
|
1916: Thromboinflammation, Increased
|
Under Development |
1.96 |
| 422 |
Binding of SARS-CoV-2 to ACE2 in enterocytes leads to intestinal barrier disruption |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
None
|
Under Development |
1.96 |
| 428 |
Binding of S-protein to ACE2 in enterocytes induces ACE2 dysregulation leading to gut dysbiosis |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
None
|
Under Development |
1.96 |
| 430 |
Binding of SARS-CoV-2 to ACE2 leads to viral infection proliferation |
Sally Mayasich |
BY-SA |
1739: Binding to ACE2
|
1939: Viral infection and host-to-host transmission, proliferated
|
Under Development |
1.96 |
| 319 |
Binding to ACE2 leading to lung fibrosis |
Young Jun Kim |
BY-SA |
1740: Induced dysregulation of ACE2
|
1276: Lung fibrosis
|
Under Development |
1.96 |
| 320 |
Binding of SARS-CoV-2 to ACE2 receptor leading to acute respiratory distress associated mortality |
Young Jun Kim |
BY-SA |
1739: Binding to ACE2
|
351: Increased Mortality
|
Under Development |
1.96 |
| 374 |
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis |
Anna Price |
BY-SA |
1739: Binding to ACE2
|
1841: Encephalitis
|
Under Development |
1.96 |
| 379 |
Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation |
Shihori Tanabe |
All rights reserved |
1739: Binding to ACE2
|
1846: Thrombosis and Disseminated Intravascular Coagulation
|
Under Development |
1.96 |
| 381 |
Binding of viral S-glycoprotein to ACE2 receptor leading to dysgeusia |
Young Jun Kim |
BY-SA |
1739: Binding to ACE2
|
1850: dysgeusia
|
Under Development |
1.96 |
| 382 |
Angiotensin II type 1 receptor (AT1R) agonism leading to lung fibrosis |
Young Jun Kim |
BY-SA |
1851: Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)
|
1276: Lung fibrosis
|
Under Development |
1.96 |
| 383 |
Inhibition of Angiotensin-converting enzyme 2 leading to liver fibrosis |
Young Jun Kim |
BY-SA |
1740: Induced dysregulation of ACE2
|
344: Increase, Liver fibrosis
|
Under Development |
1.96 |
| 392 |
Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation |
Penny Nymark |
BY-SA |
2 MIEs
|
1868: Hyperinflammation
|
Under Development |
1.96 |
| 394 |
SARS-CoV-2 infection of olfactory epithelium leading to impaired olfactory function (short-term anosmia) |
Sandra Coecke |
BY-SA |
1739: Binding to ACE2
|
1873: impaired olfactory function (anosmia)
|
Under Development |
1.96 |
| 395 |
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on pericytes leads to disseminated intravascular coagulation resulting in cerebrovascular disease (stroke) |
Magda Sachana |
BY-SA |
1739: Binding to ACE2
|
1875: Cerebrovascular disease (stroke)
|
Under Development |
1.96 |